Analysis Of Some Of Vanguard's Bond Funds
Scott Arterburn - at Seeking Alpha - Wed Dec 10, 10:00AM CST
BIV: 85.48 (+0.19), BSV: 80.27 (+0.11), VCIT: 86.36 (+0.10), BLV: 94.33 (+0.63), VCSH: 79.81 (+0.06), BND: 82.94 (+0.19), VGLT: 78.71 (+0.86), VCLT: 91.80 (+0.35), VGSH: 61.04 (+0.07), VGIT: 64.80 (+0.17)
U.S. corporate bond sales break annual record
Seeking Alpha - at Seeking Alpha - Tue Dec 02, 4:09AM CST
SLQD: 50.24 (unch), SHYG: 47.24 (-0.13), SJNK: 28.42 (-0.25), SCPB: 30.59 (+0.02), VCSH: 79.81 (+0.06), HYGH: 90.60 (-0.42), HYND: 21.10 (-0.10), IBCE: 97.03 (+0.19), FCOR: 50.06 (+0.01), XOVR: 25.83 (-0.04), BSCK: 21.14 (+0.05), BSCH: 22.71 (+0.02), BSCI: 21.15 (unch), BSCF: 21.70 (+0.02), BSCG: 22.14 (-0.02), TYTE: 39.62 (-0.13), CSJ: 105.13 (+0.03), BSCE: 21.13 (+0.01), WYDE: 40.03 (+0.04), BSJK: 24.58 (-0.22), VCLT: 91.80 (+0.35), BSJI: 25.35 (-0.21), BSJJ: 24.30 (-0.26), BSJH: 25.65 (-0.16), BSJG: 25.55 (-0.20), IGHG: 76.60 (-0.38), BSJF: 25.66 (-0.19), BSJE: 26.21 (+0.01), THHY: 23.55 (-0.21), CBND: 32.28 (-0.06), MDT: 71.34 (-0.65), VCIT: 86.36 (+0.10), ANGL: 26.52 (+0.07), HYLD: 39.83 (+0.38), UJB: 53.00 (-0.26), COBO: 100.75 (unch), JNK: 37.46 (-0.28), SJB: 29.08 (+0.04), HYS: 99.14 (-0.82), QLTC: 48.05 (unch), CLY: 61.03 (+0.22), LWC: 41.17 (+0.04), QLTA: 51.78 (+0.06), HYLS: 48.63 (-0.48), CRED: 111.35 (-0.01), HYG: 86.89 (-0.31), ITR: 34.24 (+0.05), HYZD: 22.96 (-0.10), HYHG: 70.68 (-0.83), LQD: 119.29 (-0.04), CORP: 102.61 (-0.10), CIU: 109.56 (+0.24), IGS: 29.33 (+0.57)
Vanguard Intermediate-Term Corporate Bond ETF announces monthly distribution of $0.234
Seeking Alpha - at Seeking Alpha - Fri Nov 28, 4:11AM CST
VCIT: 86.36 (+0.10)
A New Corporate Bond ETF from FlexShares Hits the Market - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Tue Nov 25, 7:00AM CST
FlexShares debuts a new type of corporate bond ETF using a scoring system to pick securities for inclusion.
VCIT: 86.36 (+0.10), LQD: 119.29 (-0.04), SKOR: 50.39 (+0.07), CIU: 109.56 (+0.24)
FlexShares expands its fixed income ETF portfolio with a new launch
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 10:59AM CST
ITR: 34.24 (+0.05), VCIT: 86.36 (+0.10), SKOR: 50.39 (+0.07), CIU: 109.56 (+0.24)
The Next Big Short Strategy: Rise And Fall Of Fixed Income ETFs
Macro Strategist - at Seeking Alpha - Mon Nov 03, 10:11AM CST
VCIT: 86.36 (+0.10), SJNK: 28.42 (-0.25), HYEM: 22.23 (-0.11), VCSH: 79.81 (+0.06), HYLD: 39.83 (+0.38), TLT: 127.60 (+1.56), JNK: 37.46 (-0.28), HYS: 99.14 (-0.82), SCHO: 50.64 (+0.02), EMB: 106.04 (-0.66), EMLC: 20.74 (-0.25), HYG: 86.89 (-0.31), IEI: 123.06 (+0.36), IEF: 107.16 (+0.54), UST: 57.21 (+0.61), PHB: 18.23 (-0.17), VCLT: 91.80 (+0.35), TMV: 30.97 (-1.15), LEMB: 44.84 (-0.35), PCY: 27.06 (-0.17), BSJF: 25.66 (-0.19), ELD: 40.60 (-0.30), LQD: 119.29 (-0.04), SHY: 84.65 (+0.05), BIL: 45.73 (unch), CIU: 109.56 (+0.24), VGSH: 61.04 (+0.07), SHV: 110.26 (unch)
Vanguard Intermediate-Term Corporate Bond ETF Experiences Big Inflow
ETFChannel.com - Wed Sep 10, 10:04AM CDT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard Intermediate-Term Corporate Bond ETF where we have detected an approximate $51.6 million dollar inflow --...
VCIT: 86.36 (+0.10)
Notable ETF Inflow Detected - VCIT
ETFChannel.com - Tue Sep 02, 10:18AM CDT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard Intermediate-Term Corporate Bond ETF where we have detected an approximate $173.9 million dollar inflow --...
VCIT: 86.36 (+0.10)
Why Diversification Doesn���t Always Mitigate Risk
at The Street - Mon Jul 28, 12:38PM CDT
A colorful, balanced asset-class-based pie chart does not equate to sensible level of risk.
VCIT: 86.36 (+0.10), GOOGL: 498.16 (-17.68)
Heat Biologics, Inc. to Present at "TEN"; Noble Financial Capital Markets' Tenth Annual Equity Conference on Tuesday, January 21, 2014
Marketwire - Fri Jan 17, 7:05AM CST
Heat Biologics, Inc. (NASDAQ: HTBX), a clinical stage biopharmaceutical company focused on the development of novel cancer immunotherapies, announced today that Jeff Wolf, Chief Executive Officer, will be presenting at "TEN"; Noble Financial Capital Markets' Tenth Annual Equity Conference on Tuesday, January 21, 2014 at 8:30 a.m. Eastern Time.
HTBX: 4.00 (-0.08), FREE: 0.09 (-0.01), VCIT: 86.36 (+0.10)